Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Vietnam Stocks: Imexpharm, Truong Thanh, Tay Nguyen Electricity

Dec. 5 (Bloomberg) -- Shares of the following companies had unusual moves in Vietnam trading. Stock symbols are in parentheses and prices are as of the close in Ho Chi Minh City.

The VN Index, the benchmark measure of the Ho Chi Minh City Stock Exchange, rose for a second day, gaining 1.9 percent to a three-week high of 391.19.

Imexpharm Pharmaceutical Joint-Stock Co. (IMP VN), a pharmaceuticals manufacturer and trader, gained for the first time since Nov. 8. The shares jumped 5 percent to 36,000 dong, the biggest gain since June 22. Imexpharm will buy back 500,000 shares from Dec. 9, it said in a statement on the bourse’s website.

Truong Thanh Furniture Corp. (TTF VN), Vietnam’s biggest listed furniture maker, rallied 3.5 percent, to 5,900 dong. The company will form a timber venture with Japan’s Oji Paper Co. to plant a forest in the southern Vietnamese province of Phu Yen, according to a statement on the exchange’s website. Truong Thanh will have a 51 percent stake in the project, the statement said.

Tay Nguyen Electricity Investment Joint-Stock Co. (TIC VN) a power company that also engages in construction of civil engineering works and production of rubber products, rose 4 percent to 7,900 dong. The company plans to buy back 200,000 shares from Dec. 12, according to a statement on the exchange’s website.

To contact the reporter on this story: Nguyen Dieu Tu Uyen in Hanoi at uyen1@bloomberg.net

To contact the editor responsible for this story: Darren Boey at dboey@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.